The aged rhesus macaque manifests Braak stage
III/IV Alzheimer's-like pathology
Constantinos D. Paspalas, Yale School of Medicine
Becky C. Carlyle, Yale School of Medicine
Shannon Leslie, Yale School of Medicine
Todd M Preuss, Emory University
Johanna L. Crimins, Yale School of Medicine
Anita J. Huttner, Yale School of Medicine
Christopher H. van Dyck, Yale School of Medicine
Douglas L. Rosene, Boston University
Angus C. Nairn, Yale School of Medicine
Amy F.T. Arnsten, Yale School of Medicine
Journal Title: Alzheimer's and Dementia
Volume: Volume 14, Number 5
Publisher: Elsevier: 12 months | 2018-05-01, Pages 680-691
Type of Work: Article | Post-print: After Peer Review
Publisher DOI: 10.1016/j.jalz.2017.11.005
Permanent URL: https://pid.emory.edu/ark:/25593/tqj7w
Final published version: http://dx.doi.org/10.1016/j.jalz.2017.11.005
Copyright information:
© 2017 The Authors
This is an Open Access work distributed under the terms of the Creative
Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Accessed November 25, 2021 12:29 AM EST
HHS Public Access
Author manuscript
Author Manuscript
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Published in final edited form as:
Alzheimers Dement. 2018 May ; 14(5): 680–691. doi:10.1016/j.jalz.2017.11.005.
The aged rhesus macaque manifests Braak stage III/IV
Alzheimer’s-like pathology
Constantinos D. Paspalasa,*, Becky C. Carlyleb, Shannon Leslieb, Todd M. Preussc,
Johanna L. Criminsa, Anita J. Huttnerd, Christopher H. van Dycka,b,e, Douglas L. Rosenef,
Angus C. Nairnb, and Amy F. T. Arnstena,b,**
Author Manuscript
aDepartment
of Neuroscience, Yale School of Medicine, New Haven, CT, USA
bDepartment
of Psychiatry, Yale School of Medicine, New Haven, CT, USA
cDivision
of Neuropharmacology and Neurologic Diseases, Yerkes National Primate Center,
Emory University, Atlanta, GA, USA
dDepartment
of Pathology, Yale School of Medicine, New Haven, CT, USA
eDepartment
of Neurology, Yale School of Medicine, New Haven, CT, USA
fDepartment
of Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA,
USA
Abstract
Author Manuscript
Introduction: An animal model of late-onset Alzheimer’s disease is needed to research what
causes degeneration in the absence of dominant genetic insults and why the association cortex is
particularly vulnerable to degeneration.
Author Manuscript
Discussion: The aging rhesus macaque provides the long-sought animal model for exploring the
etiology of late-onset Alzheimer’s disease and for testing preventive strategies.
Methods: We studied the progression of tau and amyloid cortical pathology in the aging rhesus
macaque using immunoelectron microscopy and biochemical assays.
Results: Aging macaques exhibited the same qualitative pattern and sequence of tau and amyloid
cortical pathology as humans, reaching Braak stage III/IV. Pathology began in the young-adult
entorhinal cortex with protein kinase A-phosphorylation of tau, progressing to fibrillation with
paired helical filaments and mature tangles in oldest animals. Tau pathology in the dorsolateral
prefrontal cortex paralleled but lagged behind the entorhinal cortex, not afflicting the primary
visual cortex.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
*
Corresponding author. Tel.: +1-203-785-5230; Fax: + 1-203-785-5263. **Corresponding author. Tel.: +1-203-785-4431; Fax:
+1-203-785-5263.
The authors have declared that no conflict of interest exists.
Supplementary data
Supplementary data related to this article can be found at https://doi.org/10.1016/j.jalz.2017.11.005.
Paspalas et al.
Page 2
Author Manuscript
Keywords
Amyloid; Entorhinal cortex; Prefrontal cortex; Ryanodine receptor calcium leak; Tau
phosphorylation; Animal model of disease
1. Introduction
Author Manuscript
Tauopathy is the hallmark of Alzheimer’s disease (AD), caused by abnormal
phosphorylation/aggregation of the microtubule-associated tau protein; hyperphosphorylated
tau fibrillates as paired helical filaments (PHFs) in neurofibrillary tangles (NFTs) [1–3].
NFTs accumulate within degenerating neurons and correlate with cognitive deficits [4,5]. In
late-onset AD, fibrillated tau immunoreactivity first arises in the “cell islands” of the layer II
entorhinal cortex (ERC; Braak stage I/II), with the earliest signs of labeled neurites evident
in young-middle age (Braak stage Ia/b). Pathology continues to worsen in the ERC and
begins in the pyramidal neurons of the association cortex, for example, the dorsolateral
prefrontal cortex (dlPFC; Braak stage III/IV), progressing to involve the primary visual
cortex (V1) at end-stage disease (Braak stage V/VI) [1,5,6]. Braak stage III/IV associates
primarily with memory impairments, befitting the extensive degeneration in the ERC,
whereas explicit dementia is associated with Braak stage V/VI, when there is extensive
degeneration in the association cortices [5]. Amyloidosis, the other hallmark pathology in
AD, is caused by amyloid β (Aβ) peptides deposited extracellularly in senile plaques. Aβ is
generated after the sequential cleavage of amyloid precursor protein (APP) by β- and γsecretase in the endocytotic amyloidogenic pathway [7,8]. Unlike NFTs, the amyloid load
correlates weakly with cognitive deficits [4,5], but refer to the study by Murphy and Levine
[9].
Author Manuscript
In vitro and transgenic mouse models have transformed AD research, revealing how genetic
insults lead to tau and amyloid pathology in familial early-onset AD [10]. However, genetic
models do not address questions pertaining to the native course of the most common, lateonset AD. Why does advancing age lead to the same phenotype as dominantly heritable
early-onset disease, and why does AD present a specific pattern and sequence of
degeneration that progresses along interconnected glutamatergic neurons in the association
cortex [11]? These questions require a model species with extensive association cortex,
where both tau and amyloid pathologies arise naturally with advancing age.
Author Manuscript
While nonhuman primates have extensive association cortex and manifest amyloid
pathology similar to humans, early research failed to detect AD-like tau pathology with
neuronal degeneration (reviewed in [12]), supporting the hypothesis that AD is a
phylogenetic, human-specific disease [13]. There is since a single report of true tau
pathology with PHFs in the prefrontal cortex of a chimpanzee [14], but hominids are not
available for invasive research. We studied rhesus macaques from young to extreme old age
(up to 38 years of age) using immunoelectron microscopy to capture early stages of tau
phosphorylation and its progression to fibrillation in the ERC and dlPFC. We report that
aging macaques exhibit the same qualitative pattern and sequence of tau pathology as
humans, reaching Braak stage III/IV in the oldest animals. Perfusion-fixation of the brain
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 3
Author Manuscript
allowed the visualization of early tau pathology as well as tracing of the amyloidogenic
pathway in situ, which is unprecedented and not possible in humans after death. We propose
that the aging rhesus macaque can model the development of AD pathology, recapitulating
those early, preclinical events that initiate age-related degeneration.
2. Methods
All procedures were approved by the Boston, Emory, and Yale Universities and National
Institute on Aging Institutional Animal Care and Use Committees and conformed to the
Guide for the Care and Use of Laboratory Animals of the Office of Laboratory Animal
Welfare, National Institutes of Health.
2.1.
Biochemical assays
Author Manuscript
Brain samples from 11 rhesus macaques (aged 4.5–31 years) of the Yale and Emory
Universities’ brain collections were used for the biochemical assays. Animals and tissue
sampling procedures are described in Supplementary Methods.
Author Manuscript
2.1.1. Tau fractionation—Flash-frozen tissue was homogenized in Tris-buffered saline
(TBS; 50 mM Tris pH 7.4, 274 mM NaCl, 5 mM KCl, plus cOmplete EDTA-free protease
inhibitor and PhosSTOP [Roche, Indianapolis, IN] phosphatase inhibitor). The homogenate
was centrifuged at 150,000 × g for 20 minutes at 4°C, and the supernatant was removed and
frozen as the S1 TBS-soluble tau fraction. The pellet was resuspended in P1 buffer (0.8 M
NaCl, 10% sucrose, 10 mM Tris pH 7.4, 1 mM EGTA, and cOmplete protease inhibitor) and
respun under the same conditions. The S2 supernatant was removed, and sarkosyl added to a
final concentration of 1%. The supernatant was heated for 1 hour at 37°C and centrifuged for
1 hour at 150,000 × g at 4°C, yielding a supernatant containing salt-extractable tau and S3,
and a pellet containing P3 sarkosyl-insoluble tau. P3 sarkosyl-insoluble tau was not detected
in either the ERC or dlPFC.
Author Manuscript
2.1.2. Immunoblotting—A rabbit polyclonal antibody against human tau (Dako A0024;
Agilent, Santa Clara, CA) was used for all immunoblots. The primary antibody was
visualized with the IRDye 680 anti-rabbit secondary antibody in the Odyssey infrared
scanner (LI-COR Biosciences, Lincoln, NE). Bands were quantified using ImageJ (National
Institutes of Health), and correlation analysis was performed using Prism 7 (GraphPad, La
Jolla, CA). Band proportion analysis was normalized within lane, representing the
proportion of total tau in each band. Total tau measurements were normalized using Amido
Black total protein stain (Sigma-Aldrich, St. Louis, MO). The membranes were visualized
using the ChemiDoc instrument (Bio-Rad, Hercules, CA). After tau labeling, further
analysis of the ERC blots was attempted that required stripping, and the Amido Black signal
was poor thereafter. Therefore, a parallel check was performed to normalize the ERC data by
running an input tau check (noncentrifuged homogenate). The same proportional patterns of
total tau distribution were observed between fractions using this check.
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
2.2.
Page 4
Light and electron immunomicroscopy
Author Manuscript
The brains of 10 rhesus macaques (aged 7–38 years) from four brain collections (Yale,
Boston, and Emory Universities and the National Institute on Aging) were used for the
anatomy studies. Animals including cognitive characterization (if applicable), anesthesia,
and histological processing are described in Supplementary Methods.
2.2.1. Antibodies—Primary antibodies were raised in rabbits or mice and complexed
with species-specific goat secondary or tertiary antibodies. Primaries raised in different
species were selected for dual immunocytochemistry.
Author Manuscript
The following primary antibodies against human proteins were used: (1) mouse antiphosphoSer214-tau IgM (clone CP3) [15] at 1:200 (generously provided by Dr. Peter
Davies, Litwin-Zucker Research Center); (2) mouse antiphosphoSer202 + Thr205-tau IgG1k
(clone AT8) at 1:300 (MN1020; Thermo Fisher Scientific, Waltham, MA); (3) mouse antiphosphoThr181-tau IgG1k (clone AT270) at 1:200 (MN1050; Thermo Fisher Scientific); (4)
mouse anti-phosphoThr231-tau IgG1k (clone AT180) at 1:200 (MN1040; Thermo Fisher
Scientific); (5) rabbit anti-phosphoSer2808-RyR2 IgG at 1:250 (ab59225; Abcam,
Cambridge, MA); (6) rabbit anti-Aβ1–42 IgG at 1:100 (AB5078P; EMD Millipore, Billerica,
MA); (7) mouse anti-Aβ1–42 IgG2b (clone MOAB-2) at 1:300 (NBP2-13075; Novus,
Littleton, CO); and (8) rabbit anti-APP (C-terminus) IgG at 1:600 (A8717; Sigma-Aldrich).
Author Manuscript
The following secondary and tertiary antibodies were used: goat anti-rabbit F(ab′)2, biotinconjugated, at 1:500 (Jackson ImmunoResearch Labs, West Grove, PA); (2) goat anti-mouse
F(ab′)2, biotin-conjugated, at 1:500 (Jackson ImmunoResearch Labs); (3) goat anti-rabbit
Fab′, 1.4-nm gold cluster-conjugated, at 1:200 (Nanoprobes, Yaphank, NY); (4) goat antimouse Fab′, 1.4-nm gold cluster-conjugated, at 1:200 (Nanoprobes); and (5) goat anti-biotin
IgG, 1.4-nm gold cluster-conjugated, at 1:300 (Nanoprobes).
Author Manuscript
2.2.2. Single and dual immunocytochemistry—Sections underwent three freezethaw cycles in liquid nitrogen to permeabilize cell membranes and were subsequently
processed free-floating for immunocytochemistry. Nonspecific reactivity was suppressed
with 10% non-immune goat serum and 2% IgG-free bovine serum albumin (BSA) in 50 mM
TBS. The sections were additionally treated with 0.5% sodium borohydride in TBS to
quench nonreactive aldehydes before protein blocking. Normal sera and BSA were
purchased from Jackson ImmunoResearch Labs. Acetylated BSA was from Aurion
(Wageningen, The Netherlands). All chemicals and supplies for electron microscopy were
purchased from Sigma-Aldrich and Electron Microscopy Sciences (Hatfield, PA),
respectively.
For peroxidase single immunolabeling, sections were incubated for 36 hours at 4°C in
primary antibodies in TBS plus 2% non-immune goat serum (NTBS) and transferred for 2
hours at room temperature (RT) to species-specific biotinylated F(ab′)2 fragments in NTBS
and finally to avidin-biotinylated peroxidase (1:200 in TBS; Vector, Burlingame, CA) for 2
hours at RT. Peroxidase activity was visualized in 0.05% diaminobenzidine (DAB) in TBS
with the addition of 0.01% hydrogen peroxide for 8–12 minutes.
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 5
Author Manuscript
For gold single immunolabeling, antibodies were diluted in NTBS and applied for 36 hours
at 4°C. The sections were washed in NTBS supplemented with 0.07% Tween 20 and 0.1%
acetylated BSA (gold buffer) and incubated for 2 hours at RT with species-specific Fab′
conjugated to 1.4-nm gold cluster. After fixation in 1% buffered glutaraldehyde, gold was
enhanced under a mercury-vapor safelight for 8–10 minutes on ice with a silver
autometallographic developer (HQ Silver; Nanoprobes). Alternatively, after the biotinylated
secondary antibody, the sections were incubated in 1.4-nm gold-conjugated anti-biotin IgG
for 2 hours at RT and silver-enhanced as described previously.
Author Manuscript
For peroxidase-gold dual immunolabeling, sections were incubated for 48 hours at 4° C in a
mixture of two primary antibodies. Secondary antibodies were used for 3 hours at RT as a
mixture of species-specific 1.4-nm gold and biotin conjugates. Gold was silver-enhanced as
in a single immunocytochemistry. The biotinylated antibodies were complexed with
peroxidase and developed with the DAB chromogenic reaction as described previously.
Alternatively, the labeling sequence was reversed, so that previously gold-labeled antigens
were visualized with DAB, and vice versa.
For each immunocytochemical series, a parallel set of experiments controlled for crossreactivities and methodological artifacts (Supplementary Methods). Labeled sections were
processed for light and electron microscopy imaging as described in Supplementary
Methods.
3. Results
3.1.
Early development of tau pathology in the ERC
Author Manuscript
The rhesus macaque allows high-resolution, timely detection of phosphorylated yet not
fibrillated tau species that degrade in humans after death. Tau normally functions to stabilize
microtubules but detaches and aggregates when phosphorylated by cyclic adenosine
monophosphate (cAMP)-protein kinase A (PKA) [15]. PKA-phosphorylated tau (pSer214tau) was seen in layer II ERC cell islands in young-adult macaques (7–9 years; Fig. 1A),
consistent with early tau pathology in the ERC of young-adult humans (Braak stage Ia/b).
PKA-phosphorylated tau aggregated along microtubules in dendrites (Fig. 1B–D),
“entrapping” transporting endosomes as captured in Fig. 1D. PKA-phosphorylated tau was
also found in transporting endosomes and trafficked between neurons at plasma membrane
endo/exocytotic profiles (Fig. 1E).
Author Manuscript
3.1.1. Tau pathology and Ca2+ dysregulation in the synapse—In the youngadult ERC, pSer214-tau aggregated within glutamatergic-like synapses onto dendrites and
on smooth endoplasmic reticulum (SER) cisterns underneath the synapses. These Ca2+
storing SER elements were unique in that they were enlarged and extensively elaborated and
often bridged the synapse to a mitochondrion (Fig. 1F and 1G). We have termed this SER
specialization, by analogy with the spine apparatus, “dendritic subsynaptic reticulum”
(DSR). The pairing of the DSR with the pSer214-tau-afflicted synapses suggests a possible
involvement of internal Ca2+ in tau pathology. Supporting this hypothesis, PKAphosphorylation of RyR2 (pSer2808-RyR2), which causes Ca2+ leak from the SER in
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 6
Author Manuscript
cardiac and brain cells [16,17], was found on the DSR cisterns (Fig. 1H and 1I), suggesting
that dysregulated PKA-Ca2+ signaling may have an early role in instigating tau pathology.
3.2.
Fibrillated tau in the ERC
Author Manuscript
The pattern and sequence of tau fibrillation in the aging macaques’ cortex, revealed with the
AT8 antibody against PHF-tau, corresponded to Braak staging of AD using the same
antibody [6]. In “younger” aged macaques (24–26 years), there was mild AT8 reactivity in
the outer tier of layer II stellate cell islands in the ERC, including in a 26-year-old macaque
with confirmed cognitive deficits (Fig. 2A and Supplementary Table), consistent with Braak
stage I/II. With still older age (33–34 years), AT8 labeling became intense and widespread
throughout the cell islands of the layer II (Fig. 2B), with sporadic labeling of pyramidal cells
in the deeper ERC (and dlPFC; see below), consistent with Braak stage III. In the oldest
macaque examined, a 38-year-old macaque with pronounced cognitive deficits
(Supplementary Table), mature NFTs were observed in both layer II (Fig. 2C) and layer V
(Fig. 2D) ERCs, consistent with Braak stage III/IV.
Author Manuscript
To directly demonstrate fibrillated tau in aged macaques (33–34 years), we used high-power
immunoelectron microscopy. Layer II ERC neurons contained loose fibrillar clusters that
reacted with AT8 and other antibodies against human PHF-tau (Fig. 2E and 2F, and
Supplementary Fig. 1), consistent with NFTs and neuropil threads. Fibrils were distinct from
intermediate filaments in glia (Supplementary Fig. 2) and composed of straight and paired
10-nm filaments with abrupt endings and the typical 80-nm helical periodicity of PHFs in
AD (Fig. 2G–I) [18]. Layer II ERC neurons also showed typical signs of AD-like
degeneration, including large autophagic vacuoles in the soma and proximal dendrites (Fig.
2J and 2K), microglial engulfment, argyrophilia, massive accumulation of late-phase
lysosomes, and dystrophic neurites (Fig. 3A–D). “Ghost dendrites” (Fig. 2K) were seen in
AT8-reactive pretangle neurons, indicating severe cellular disruption before full NFT
formation. Notably, pyramidal neurons in the layer V ERC of the same macaques displayed
a “healthy” ultrastructure with no signs of vacuolar degeneration or autophagy
(Supplementary Fig. 3).
Author Manuscript
Because the macaque data were obtained after transcardial fixation and zero postmortem
interval (PMI), we tested how these conditions compare with conditions used in
neuropathology. The brain of a 28-year-old macaque was removed after death (1 hour PMI)
and immersion-fixed in buffered formalin, which is the routine processing of human brains.
Even with this short PMI, the new protocol resulted in the dissolution of most of AT8immunoreactivity in the ERC, likely due to loss of partially fibrillated tau from pretangle
neurons (Supplementary Fig. 4).
3.3.
Tau pathology in the dlPFC
In humans, tau pathology extends from the ERC to the association cortex with advancing
age. The pattern is similar in aging macaques, with tau phosphorylation appearing in the
association cortex at a later age than in the ERC. Thus, pSer214-tau is detected in pyramidal
neurons of the aged dlPFC (31–34 years; Fig. 4A), but not in the young-adult dlPFC [19] or
in resilient primary cortices (Supplementary Fig. 5). Labeling was found in spines at
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 7
Author Manuscript
glutamatergic-like synapses and over the spine apparatus, similar to pSer214-tau aggregating
over synapses and the DSR in ERC dendrites (compare Fig. 4B to Fig. 1F).
Consistent with a later appearance of tau phosphorylation in the association cortex, tau
fibrillation was only sporadic in the aged dlPFC (Fig. 4C). AT8 labeled PHFs (Fig. 4D and
4E), consistent with Braak stage III/IV. Biochemical assays confirmed that tau
phosphorylation is less advanced in the dlPFC than in the ERC (Fig. 4F and 4G,
Supplementary Figs. 6 and 7), similar to the progression of tau pathology in aging humans.
3.4.
Amyloid pathology and endosomal trafficking
Author Manuscript
Amyloid pathology was also observed in aged macaques. However, despite peak fibrillary
pathology and neuronal degeneration, the layer II ERC showed minimal amyloidosis, with
most of the extracellular amyloid deposits found in the layer V, similar to the pattern in the
human ERC. Labeling against Aβ1–42 revealed parenchymal amyloid plaques with a fibrous
core composed of straight, unbranching 10-nm fibrils corresponding to fibrous amyloid (Fig.
5A–C) as well as extensive vascular amyloid deposition (not shown). Intracellular Aβ was
found in endosomes localized next to mitochondria (Fig. 5D), a likely site of γ-secretase
activity [20], and on the plasma membrane in dendrites and axons (Fig. 5E and 5F). Such
membrane appositions of Aβ endosomes may be capturing release into the intercellular
space, for example, from an axon in Fig. 5F.
Author Manuscript
In vitro studies have shown that “entrapping” APP in endosomes drives cleavage to Aβ [21].
In the macaque, phosphorylated tau surrounds endosomes and potentially hinders transport
along the microtubules, both in early stages of phosphorylation (Fig. 1D) and in later
fibrillated states (Fig. 5G). To determine whether these endosomes may contain APP, we
double labeled for APP and AT8. In the aged ERC, APP-transporting endosomes (please
note the tagged C-terminus is on the cytoplasmic aspect of the endosomal membrane) were
surrounded by fibrillated tau aggregates (Fig. 5H). Similarly in the dlPFC, APP was
trafficked in endosomes (Fig. 6A–D) and internalized via clathrin-mediated endocytosis
(Fig. 6B), as it is known from research in vitro [8]. As in the ERC, fibrillated tau aggregated
on APP-transporting endosomes (Fig. 6E).
4. Discussion
Author Manuscript
This study reports that the aging rhesus macaque exhibits the qualitative pattern and
sequence of tau and amyloid pathology observed in humans. Tau phosphorylation and
fibrillation arise in the same cell types, layers and cortical regions, and in the same
progressive sequence as in AD, reaching Braak stage III/IV in the oldest animals. Aged
macaques manifested true AD-like tau pathology with mature NFTs and PHFs of the typical
ultrastructure. Moreover, there are Aβ-reactive senile plaques and neurons undergoing
vacuolar degeneration and autophagy. Taken together, the data establish the rhesus macaque
as a valid animal model for late-onset AD. Pathology in humans is more extensive, as to be
expected given the great expansion of association cortical connections and the longer
lifespan.
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 8
Author Manuscript
In neuropathology, human AD brains are collected after death and immersion-fixed in
formalin. Long PMI and formalin denature proteins and dramatically degrade the fine
structure. Our own controls demonstrate that early species of phosphorylated tau are
detected in the perfused macaque brain but lost after death. Thus, it is the nearly
indestructible highly fibrillated tau that mostly survives in brain autopsies. Likewise, Aβ and
APP along the endocytotic pathway cannot be visualized in humans because of the loss of
antigenicity and the extensive damage of endomembranes (e.g., Golgi and SER cisterns and
the endosomal compartment) that occur after death. In other words, early pathology, which
is lost in routine neuropathological examination, may be the key to illuminating the etiology
of the disease.
Author Manuscript
In contrast, the macaque brain is transcardially perfused with very potent fixatives to
preserve both the fine structure and antigenicity. Using this model, we traced the trafficking
of APP from the trans-Golgi to clathrin-coated membrane pits and into endosomes in
neurites, which is known to be exacerbated by the apolipoprotein E4 (APOE ε4) genotype to
increase Aβ production and risk of AD [22]. We have also captured Aβ in transporting
endosomes in association with the plasma membrane, where Aβ soluble oligomers could be
secreted into the intercellular space to have toxic effects on synapses [23]. Moreover, we
documented dissemination of tau pathology, for example, pSer214-tau trafficking between
neurons at endo/exocytotic appositions in the ERC (Fig. 1E) and dlPFC [19], consistent with
tau “seeding” known from mouse AD models [24,25]. These observations in situ would
support the diagnostic use of blood exosomes as early indicators of the intracellular milieu
of afflicted neurons [26].
Author Manuscript
It is already known that Aβ can drive tau phosphorylation in vivo [27]. Our data in the ERC
and dlPFC suggest that aggregated phosphorylated tau may “entrap” APP-transporting
endosomes, thus retaining APP and intensifying its cleavage to Aβ similar to retromer
insults [21], hence fueling a vicious cycle of degeneration; see [28] for a tau-amyloid
unifying hypothesis. This may be key for late-onset AD, where tau pathology appears before
amyloid pathology [1]. The early degeneration of the layer II ERC may destroy the “engine”
for Aβ production, and so limited amyloidosis was found there, while the gradual tau
pathology in the dlPFC may generate extensive amyloid load, for example, as seen with
amyloid-binding positron emission tomography [29]. Varied preventive/therapeutic
strategies may interrupt this vicious cycle, and the aging macaque would be a unique
opportunity to rigorously test such strategies at prodromal stages of degeneration.
Author Manuscript
The aging macaque brain may be used to observe in situ molecular changes that initiate AD
pathology in the absence of genetic insults. Researchers have long hypothesized that the
degenerative process may be fueled by Ca2+ dysregulation [30–32]. A role for internal Ca2+
was encouraged by the discovery that presenilins, the catalytic core in the γ-secretase
complex, facilitate Ca2+ efflux from SER stores [33]. Our discovery that pSer214-tau
aggregates over the DSR and the spine apparatus, both Ca2+-storing SER specializations in
ERC dendrites and dlPFC spines, respectively, supports Ca2+ involvement. Further support
is added by our finding that DSR cisterns display PKA-phosphorylated RyR2, known to
cause Ca2+ leak [16,17]. In cardiac muscle, RyR2 phosphorylation leads to Ca2+ overload of
mitochondria, inflammation, and heart failure [34]. Similar actions in higher cortical circuits
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 9
Author Manuscript
with advancing age may also lead to mitochondrial dysfunction and inflammation, both
associated with AD [35,36], as well as drive Aβ cleavage and tau phosphorylation [37–39].
Thus, the early appearance of pSer2808-RyR2 in the macaque’s ERC may model the
increased RyR Ca2+ signaling in the human cortex during early phases of tau
phosphorylation (Braak stage I/II) [40] and the increased Ca2+ flux through RyR2 in young
3xTg mice before fibrillary pathology [41].
Author Manuscript
Studies of the aging macaque may finally help explain why the association cortex is
particularly vulnerable to degeneration. Pyramidal cells in the newly evolved dlPFC
communicate via immense numbers of corticocortical glutamatergic synapses on their spines
[42] and develop excessive cAMP-PKA signaling with advanced age, related at least in part
to the loss of the phosphodiesterase PDE4A [19]. PDE4D is also reduced with advancing
age in the human dlPFC [43], suggesting that weaker regulation of cAMP in the aging
dlPFC translates across primate species. Dorsolateral PFC glutamatergic synapses are
regulated in a remarkable manner, whereby feedforward cAMP-Ca2+ signaling controls the
open-state of hyperpolarization-activated cyclic nucleotide-gated and K+ channels to
dynamically gate network strength [44]. Layer II “grid cells” in the ERC also serve as a hub
for association cortical connections [45], and, like dlPFC neurons, are dynamically
modulated by cAMP-hyperpolarization-activated cyclic nucleotidegated channel signaling
[46,47]. These glutamatergic synapses in the dlPFC and ERC are the foundation of flexible,
higher cognition but may also serve as an engine of pathology when cAMP-Ca2+ signaling
is not held in check. Importantly, the number of corticocortical synapses in dlPFC and ERC
increases greatly over evolution—rodents << monkeys < apes < humans—corresponding to
the degree of AD-like pathology in these species [42,48,49].
Author Manuscript
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
The authors are grateful to Dr. Peter R. Rapp of the National Institute on Aging, National Institutes of Health, for
contributing brain tissue of a cognitively characterized rhesus macaque. Dr. Rapp’s contribution was supported in
part by the Intramural Research Program of the NIA. We thank Ms. Marianne Horn (Yale University) for her expert
assistance with transcardial perfusions, Dr. Peter Davies (Litwin-Zucker Center for Alzheimer’s Disease and
Memory Disorders) for the CP3 antibody, and Dr. Naruhiko Sahara (University of Florida) for his advice on tau
biochemistry. This work was supported by the National Institutes of Health (DP1AG047744, P50-AG047270, and
RO1 AG043640); the Yerkes National Primate Research Center (OD P51OD11132); the Yale Alzheimer’s Disease
Research Unit; and a gift in memory of Elsie Louise Torrance Higgs (Muinntir Bana-Ghaisgeach), who had faith
that discoveries in brain research would help to alleviate human suffering.
Author Manuscript
Funding sources had no involvement in study design; in the collection, analysis, and interpretation of data; in the
writing of the report; and in the decision to submit the article for publication.
References
[1]. Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer
disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol 2011;70:960–9. [PubMed:
22002422]
[2]. Iqbal K, Liu F, Gong CX. Tau and neurodegenerative disease: the story so far. Nat Rev Neurol
2016;12:15–27. [PubMed: 26635213]
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 10
Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
[3]. Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci 2016;17:5–21.
[PubMed: 26631930]
[4]. Giannakopoulos P, Herrmann FR, Bussieère T, Bouras C, Kövari E, Perl DP, et al. Tangle and
neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease.
Neurology 2003; 60:1495–500. [PubMed: 12743238]
[5]. Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of Alzheimer
disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol
Exp Neurol 2012; 71:362–81. [PubMed: 22487856]
[6]. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K. Staging of Alzheimer diseaseassociated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta
Neuropathol 2016;112:389–404.
[7]. LaFerla FK, Green KN, Oddo S. Intracellular amyloid-β in Alzheimer’s disease. Nat Rev Neurosci
2007;8:499–509. [PubMed: 17551515]
[8]. O’Brien RJ, Wong PC. Amyloid precursorprotein processing and Alzheimer’s disease. Annu Rev
Neurosci 2011;34:185–204. [PubMed: 21456963]
[9]. Murphy MP, Levine H, 3rd. Alzheimer’s disease and the β-amyloid peptide. J Alzheimers Dis
2010;19:311–23. [PubMed: 20061647]
[10]. Morrissette DA, Parachikova A, Green KN, LaFerla FM. Relevance of transgenic mouse models
to human Alzheimer disease. J Biol Chem 2009;284:6033–7. [PubMed: 18948253]
[11]. Bussière T, Giannakopoulos P, Bouras C, Perl DP, Morrison JH, Hof PR. Progressive
degeneration of nonphosphorylated neurofilament protein-enriched pyramidal neurons predicts
cognitive impairment in Alzheimer’s disease: stereologic analysis of prefrontal cortex area 9. J
Comp Neurol 2003;463:281–302. [PubMed: 12820162]
[12]. Finch CE, Austad SN. Commentary: is Alzheimer’s disease uniquely human? Neurobiol Aging
2015;36:553–5. [PubMed: 25533426]
[13]. Rapoport SI. Hypothesis: Alzheimer’s disease is a phylogenetic disease. Med Hypotheses
1989;29:147–50. [PubMed: 2528670]
[14]. Rosen RF, Farberg AS, Gearing M, Dooyema J, Long PM, Anderson DC, et al. Tauopathy with
paired helical filaments in an aged chimpanzee. J Comp Neurol 2008;509:259–70. [PubMed:
18481275]
[15]. Jicha GA, Weaver C, Lane E, Vianna C, Kress Y, Rockwood J, et al. cAMP-dependent protein
kinase phosphorylations on tau in Alzheimer’s disease. J Neurosci 1999;19:7486–94. [PubMed:
10460255]
[16]. Wehrens XH, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR. Ryanodine receptor/
calcium release channel PKA phosphorylation: a critical mediator ofheart failure progression.
Proc Natl Acad Sci USA 2006;103:511–8. [PubMed: 16407108]
[17]. Liu X, Betzenhauser MJ, Reiken S, Meli AC, Xie W, Chen BX, et al. Role of leaky neuronal
ryanodine receptors in stress-induced cognitive dysfunction. Cell 2012;150:1055–67. [PubMed:
22939628]
[18]. Crowther RA. Straight and paired helical filaments in Alzheimer disease have a common
structural unit. Proc Natl Acad Sci U S A 1991; 88:2288–92. [PubMed: 1706519]
[19]. Carlyle BC, Nairn AC, Wang M, Yang Y, Jin LE, Simen AA, et al. cAMP-PKA phosphorylation
of tau confers risk for degeneration in aging association cortex. Proc Natl Acad Sci U S A 2014;
111:5036–41. [PubMed: 24707050]
[20]. Pavlov PF, Wiehager B, Sakai J, Frykman S, Behbahani H, Winblad B, et al. Mitochondrial γsecretase participates in the metabolism of mitochondria-associated amyloid precursor protein.
FASEB J 2011; 25:78–88. [PubMed: 20833873]
[21]. BhallaA VetanovetzCP, MorelE ChamounZ, Di PaoloG SmallSA. The location and trafficking
routes of the neuronal retromer and its role in amyloid precursor protein transport. Neurobiol Dis
2012; 47:126–34. [PubMed: 22516235]
[22]. He X, Cooley K, Chung CH, Dashti N, Tang J. Apolipoprotein receptor 2 and X11 alpha/beta
mediate apolipoprotein E-induced endocytosis of amyloid-beta precursor protein and betasecretase, leading to amyloid-beta production. J Neurosci 2007;27:4052–60. [PubMed:
17428983]
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 11
Author Manuscript
Author Manuscript
Author Manuscript
Author Manuscript
[23]. Um JW, Kaufman AC, Kostylev M, Heiss JK, Stagi M, Takahashi H, et al. Metabotropic
glutamate receptor 5 is a coreceptor for Alzheimer Aβ oligomer bound to cellular prion protein.
Neuron 2013; 79:887–902. [PubMed: 24012003]
[24]. Liu L, Drouet V, Wu JW, Witter MP, Small SA, Clelland C, et al. Transsynaptic spread of tau
pathology in vivo. PLoS One 2012;7:e31302. [PubMed: 22312444]
[25]. de Calignon A, Polydoro M, Suárez-Calvet M, William C, Adamowicz DH, Kopeikina KJ, et al.
Propagation of tau pathology in a model of early Alzheimer’s disease. Neuron 2012;73:685–97.
[PubMed: 22365544]
[26]. Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, et al. Identification
of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood
exosomes: a case-control study. Alzheimers Dement 2015;11:600–7. [PubMed: 25130657]
[27]. Götz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau
transgenic mice induced by Aβ fibrils. Science 2001;293:1491–5. [PubMed: 11520988]
[28]. Small SA, Duff K. Linking Aβ and tau in late-onset Alzheimer’s disease: a dual pathway
hypothesis. Neuron 2008;60:534–42. [PubMed: 19038212]
[29]. Devanand DP, Mikhno A, Pelton GH, Cuasay K, Pradhaban G, Dileep Kumar JS, et al. Pittsburgh
compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer
disease, mild cognitive impairment, and healthy controls. J Geriatr Psychiatry Neurol
2010;23:185–98. [PubMed: 20430977]
[30]. Camandola S, Mattson MP. Aberrant subcellular neuronal calcium regulation in aging and
Alzheimer’s disease. Biochim Biophys Acta 2011;1813:965–73. [PubMed: 20950656]
[31]. Woods NK, Padmanabhan J. Neuronal calcium signaling and Alzheimer’s disease. Adv Exp Med
Biol 2012;740:1193–217. [PubMed: 22453989]
[32]. Alzheimer’s Association Calcium Hypothesis Workgroup. Calcium hypothesis of Alzheimer’s
disease and brain aging: a framework for integrating new evidence into a comprehensive theory
of pathogenesis. Alzheimers Dement 2017;13:178–82. [PubMed: 28061328]
[33]. Zhang H, Sun S, Herreman A, De Strooper B, Bezprozvanny I. Role of presenilins in neuronal
calcium homeostasis. J Neurosci 2010; 30:8566–80. [PubMed: 20573903]
[34]. Santulli G, Xie W, Reiken SR, Marks AR. Mitochondrial calcium overload is a key determinant
in heart failure. Proc Natl Acad Sci U S A 2015;112:11389–94. [PubMed: 26217001]
[35]. Young-Collier KJ, McArdle M, Bennett JP. The dying of the light: mitochondrial failure in
Alzheimer’s disease. J Alzheimers Dis 2012;28:771–81. [PubMed: 22057028]
[36]. Li Y, Tan MS, Jiang T, Tan L. Microglia in Alzheimer’s disease. Biomed Res Int
2014;2014:437483. [PubMed: 25197646]
[37]. Mattson MP, Engle MG, Rychlik B. Effects of elevated intracellular calcium levels on the
cytoskeleton and tau in cultured human cortical neurons. Mol Chem Neuropathol 1991;15:117–
42. [PubMed: 1663746]
[38]. Hayley M, Perspicace S, Schulthess T, Seelig J. Calcium enhances the proteolytic activity of
BACE1:an in vitro biophysical and biochemical characterization of the BACE1-calcium
interaction. Biochim Biophys Acta 2009;1788:1933–8. [PubMed: 19486882]
[39]. Hartigan JA, Johnson GV. Transient increases in intracellular calcium result in prolonged siteselective increases in Tau phosphorylation through a glycogen synthase kinase 3beta-dependent
pathway. J Biol Chem 1999;274:21395–401. [PubMed: 10409701]
[40]. Kelliher M, Fastbom J, Cowburn RF, Bonkale W, Ohm TG, Ravid R, et al. Alterations in the
ryanodine receptor calcium release channel correlate with Alzheimer’s disease neurofibrillary
and beta-amyloid pathologies. Neuroscience 1999;92:499–513. [PubMed: 10408600]
[41]. Chakroborty S, Goussakov I, Miller MB, Stutzmann GE. Deviant ryanodine receptor-mediated
calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice. J Neurosci
2009;29:9458–70. [PubMed: 19641109]
[42]. Elston GN, Benavides-Piccione R, Elston A, Zietsch B, Defelipe J, Manger P, et al.
Specializations of the granular prefrontal cortex of primates: implications for cognitive
processing. Anat Rec A Discov Mol Cell Evol Biol 2006;288:26–35. [PubMed: 16342214]
[43]. Lu T, Pan Y, Kao SY, Li C, Kohane I, Chan J, et al. Gene regulation and DNA damage in the
ageing human brain. Nature 2004;429:883–91. [PubMed: 15190254]
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 12
Author Manuscript
[44]. Arnsten AF, Wang M, Paspalas CD. Neuromodulation of thought: flexibilities and vulnerabilities
in prefrontal cortical network synapses. Neuron 2012;76:223–39. [PubMed: 23040817]
[45]. Insausti R, Amaral DG, Cowan WM. The entorhinal cortex of the monkey: II. Cortical afferents.
J Comp Neurol 1987;264:356–95. [PubMed: 2445796]
[46]. Giocomo LM, Hussaini SA, Zheng F, Kandel ER, Moser MB, Moser EI. Grid cells use HCN1
channels for spatial scaling. Cell 2011;147:1159–70. [PubMed: 22100643]
[47]. Heys JG, Hasselmo ME. Neuromodulation of I(h) in layer II medial entorhinal cortex stellate
cells: a voltage-clamp study. J Neurosci 2012;32:9066–72. [PubMed: 22745506]
[48]. Krimer LS, Hyde TM, Herman MM, Saunders RC. The entorhinal cortex: an examination of
cyto- and myeloarchitectonic organization in humans. Cereb Cortex 1997;7:722–31. [PubMed:
9408036]
[49]. DeFelipe J The evolution of the brain, the human nature of cortical circuits, and intellectual
creativity. Front Neuroanat 2011;5:29. [PubMed: 21647212]
Author Manuscript
Author Manuscript
Author Manuscript
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 13
Author Manuscript
RESEARCH IN CONTEXT
Author Manuscript
1.
Systemic review: There is great need for an animal model of late-onset
Alzheimer’s disease with naturally developing pathology, to learn why
advancing age increases risk of degeneration in highly interconnected neurons
in the association cortex. Rhesus macaques have extensive association cortex;
however, previous studies found amyloid plaques but not neurofibrillary
tangles in the aged cerebral cortex.
2.
Interpretation: We examined the association cortices of aging rhesus
macaques, including macaques of extreme old age, and found evidence of
paired helical filaments in mature neurofibrillary tangles in the oldest animals.
The pattern and sequence of tau pathology was qualitatively similar to that in
humans. Immunoelectron microscopy revealed early stages of tau and
amyloid pathology, including evidence of dysregulated calcium signaling in
the neural circuits subserving memory.
3.
Future directions: Future research can use rhesus macaques to help reveal the
etiology of Alzheimer’s disease–like degeneration in the aging cortex and to
test strategies for prevention.
Author Manuscript
Author Manuscript
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 14
Author Manuscript
Author Manuscript
Author Manuscript
Fig. 1.
Author Manuscript
Tau phosphorylation in the layer II ERC of young-adult macaque (7–9 years). (A) Stellate
cell islands (red ovals) react against pSer214-tau. (B) Correlated light/electron microscopy
shows labeling in a principal dendrite (pseudocolored). (C and D) pSer214-tau-reactive
microtubules (green-pseudocolored) in cross-sectioned (C) and longitudinally sectioned (D)
dendrites; an endosome [cyan-pseudocolored in (D)] is “entrapped” along the microtubules
by heavy aggregation of pSer214-tau. (E) Endo/exocytosis (frame and inset) of pSer214-tau;
white arrowheads point to an omegashaped profile on the plasma membrane. The elaborate
SER (see below) is pink-pseudocolored. (F and G) In ERC dendrites, both the synapse and
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 15
Author Manuscript
DSR (i.e., Ca2+-storing SER expansion subjacent to glutamatergic-like synapses)
accumulate pSer214-tau. (H and I) DSR cisterns but not the synapses react against
pSer2808-RyR2 (yellow arrowheads). Red arrowheads point to pSer214-tau; synapses are
between arrows. Scale bars, 30 μm (A), 500 nm (B), 50 nm (C,D), 200 nm (E–I).
Abbreviations: Ax, axon; Den, dendrite; DSR, dendritic subsynaptic reticulum; ERC,
entorhinal cortex; Mit, mitochondrion; pSer214-tau, protein kinase A-phosphorylated tau;
SER, smooth endoplasmic reticulum.
Author Manuscript
Author Manuscript
Author Manuscript
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 16
Author Manuscript
Author Manuscript
Author Manuscript
Fig. 2
Author Manuscript
. Tau fibrillation (AT8 labeling) in the aging macaque ERC. (A) Mild tau fibrillation is
restricted in layer II cell islands (red ovals; 26 years). (B) Advanced fibrillation in layer II
islands extends into the deeper ERC (33 years). (C and D) Mature NFTs in layer II (C) and
layer V (D) ERCs (38 years). (E) Correlated light/electron microscopy reveals loose fibril
bundles (red ovals) in the tapering proximal dendrite, consistent with NFTs (33 years). (F)
Individual fibrils react against PHF-tau (red arrowheads). (G and H) High-power microscopy
demonstrates 10-nm filament strands in a double-helix twist with a cross-over repeat of 80
nm (parallel bars), and with varying width of 10–22 nm (G), identical to PHFs in AD (H). (I)
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 17
Author Manuscript
AT8-reactive PHFs (red arrowheads) end abruptly, exposing paired 10-nm filament strands
(white arrowheads; 34 years). (J) Correlated light/electron microscopy of a pretangle layer II
stellate neuron (34 years). Asterisks mark autophagic vacuoles with multilamellar bodies in
the soma and principal dendrite (pseudocolored). (K) “Ghost” dendrite (Den) of the
degenerating neuron shown in (J); the entire cytoplasm is lysed. Scale bars, 100 μm (A and
B), 10 μm (C and D), 500 nm (E, J, and K), 100 nm (F), 40 nm (G–I). Abbreviations: AD,
Alzheimer’s disease; ERC, entorhinal cortex; NFTs, neurofibrillary tangles; PHF, paired
helical filament; pSer214-tau, protein kinase A-phosphorylated tau.
Author Manuscript
Author Manuscript
Author Manuscript
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 18
Author Manuscript
Author Manuscript
Fig. 3.
Author Manuscript
Neuronal degeneration in the layer II of the aged macaque ERC (33–34 years). (A)
Microglia (Mgl) engulfs a degenerating cellular profile containing large argyrophilic masses
(yellow arrowheads), numerous late-phase lysosomes (Ls), and lipofuscin inclusions (Lf).
(B) Detail of an AT8-labeled (red arrowheads) pretangle neuron (pseudocolored) with an
abnormal accumulation of late-phase lysosomes (Ls). (C) A senile plaque composed of AT8reactive dystrophic neurites (red arrowheads); compare with the senile plaque labeled
against Aβ in Fig. 5A. (D) A dystrophic myelinated axon (red frame) contains numerous
autophagosomes and a large vacuole in place of the inner mesaxon (asterisk). A second
myelinated axon of typical appearance (black frame) is shown for size comparison. Scale
bars, 1 μm (A, B, and D) and 30 μm (C). Abbreviations: Aβ, amyloid β; Ax, axon; ERC,
entorhinal cortex.
Author Manuscript
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 19
Author Manuscript
Author Manuscript
Fig. 4.
Author Manuscript
Author Manuscript
The pattern and sequence of tau phosphorylation in the macaque dlPFC parallels but lags
behind the ERC. (A) Layer III pyramidal neurons in the aged dlPFC (31 years) react against
pSer214-tau. (B) In dendritic spines, pSer214-tau aggregates over the synapse (between
arrows) and the spine apparatus (pink-pseudocolored). (C) Tau fibrillation, revealed with the
AT8 antibody, is sporadic in the aged dlPFC (33 years). (D and E) AT8-reactive PHFs with
80-nm helix periodicity (parallel bars in D) and abrupt endings (white arrowheads in E) as
PHFs in AD. Red arrowheads point to pSer214-tau (A and B) or PHF-tau (C—E). Scale
bars, 20 μm (A and C), 200 nm (B), 80 nm (D), and 40 nm (E). (F and G) Immunoblotting of
tau shows more advanced phosphorylation state in the ERC than dlPFC, reflected by both
increased tau at higher molecular weights (F) and increasing insolubility, S3/S1 (G).
Changes in solubility are not observed across a similar age range in the dlPFC. Total tau was
normalized to total protein (Supplementary Figs. 6 and 7). Abbreviations: AD, Alzheimer’s
disease; Ax, axon; dlPFC, dorsolateral prefrontal cortex; ERC, entorhinal cortex; NFTs,
neurofibrillary tangles; PHF, paired helical filament; pSer214-tau, protein kinase A-phosphorylated tau; Sp, spine.
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 20
Author Manuscript
Author Manuscript
Author Manuscript
Fig. 5.
Author Manuscript
Amyloid pathology in the aged macaque ERC (33–34 years). (A) A senile plaque is labeled
against Aβ. (B and C) The plaque forms extracellularly and contains cell debris and a
fibrous core (green ovals); enlarged in (C) to show individual Aβ fibrils (green arrowheads).
(D–F) Intracellular Aβ (green arrowheads) is captured in endosomes (cyan-pseudocolored)
in axons and dendrites. Note the Aβ-loaded endosomes next to the axonal plasma membrane
(traced for clarity) in (F) and the accumulation of Aβ in the widened intercellular space
(yellow asterisk). (G) Fibrils (white arrowheads) labeled with AT8 against PHF-tau (red
arrowheads) surround endosomes (cyan-pseudocolored). (H) An APP-transporting
endosome (immunogold; light green arrowhead) is surrounded by fibrils (white arrowheads)
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 21
Author Manuscript
and PHF-tau aggregates (immunoperoxidase; red arrowheads). Synapses are between
arrows. Scale bars, 20 μm (A), 200 nm (B and D–H), 30 nm (C). Abbreviations: Aβ,
amyloid β; APP, amyloid precursor protein; Ax, axon; Den, dendrite; ERC, entorhinal
cortex; Mit, mitochondrion; Mvb, multivesicular body; PHF, paired helical filament.
Author Manuscript
Author Manuscript
Author Manuscript
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 22
Author Manuscript
Author Manuscript
Author Manuscript
Fig. 6.
Author Manuscript
APP trafficking visualized in situ in the aged macaque dlPFC (33–34 years). (A) Detail of
the soma of a layer III pyramidal neuron showing APP in the trans-Golgi network. (B) APP,
which is internalized into endosomes via clathrin-mediated endocytosis, is captured in a
clathrin-coated pit (white arrowheads point to the clathrin lattice); the labeled C-terminus
protrudes intracellularly. (C and D) APP-transporting endosomes (cyan-pseudocolored) in an
axon terminal (C) and a preterminal, that is, intervaricose, axon (D). (E) High-power
magnification of tubular endosomes (cyan-pseudocolored) labeled against APP; the goldtagged C-terminus is on the cytoplasmic face. The endosome on the right is curved so that
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.
Paspalas et al.
Page 23
Author Manuscript
its middle portion is out of the section plane. This portion corresponds to the surface of the
endosome and reacts with the AT8 antibody, which shows accumulation of PHF-tau (red
arrowheads). This fortunate section plane captures the direct interaction of fibrillated tau
aggregates with a single APP-transporting endosome. Scale bars, 100 nm (A–E).
Abbreviations: APP, amyloid precursor protein; Ax, axon; dlPFC, dorsolateral prefrontal
cortex; PHF, paired helical filament.
Author Manuscript
Author Manuscript
Author Manuscript
Alzheimers Dement. Author manuscript; available in PMC 2019 May 01.